Korrektur
Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”
LUTS: Lower Urinary Tract Symptoms · 2026-07 · 18 (4)
DOI: 10.1111/luts.70070 ↗Kurz gefasst
Korrektur in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 02.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”. LUTS: Lower Urinary Tract Symptoms, 18(4). https://doi.org/10.1111/luts.70070
Vancouver
Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”. LUTS: Lower Urinary Tract Symptoms. 2026;18(4). doi:10.1111/luts.70070
BibTeX
@article{euvimed2026,
title = {Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2026},
volume = {18},
number = {4},
doi = {10.1111/luts.70070}
}
EUVIMED